Walleye Capital’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-85,638
| Closed | -$187K | – | 2707 |
|
|
2024
Q1 | $187K | Buy |
+85,638
| New | +$187K | ﹤0.01% | 1838 |
|
|
2022
Q2 | – | Sell |
-41,535
| Closed | -$111K | – | 2372 |
|
|
2022
Q1 | $111K | Buy |
+41,535
| New | +$111K | ﹤0.01% | 1658 |
|
|
2021
Q2 | – | Sell |
-17,345
| Closed | -$134 | – | 1348 |
|
|
2021
Q1 | $134 | Buy |
+17,345
| New | +$134 | 0.01% | 974 |
|
|
2020
Q1 | – | Sell |
-70,397
| Closed | -$585K | – | 613 |
|
|
2019
Q4 | $585K | Buy |
+70,397
| New | +$585K | 0.04% | 160 |
|